Score 7.5 (out of 10): PACIFIC BIOSCIENCES OF CALIF sets up for +33.9% rally in 2 months


What’s Going On Here?

PacBio, a leading developer of high-quality, highly accurate sequencing solutions, announced today that it will be participating in the upcoming Morgan Stanley 20th Annual Global Healthcare Conference in New York

Why Now?

PACIFIC BIOSCIENCES OF CALIF has triggered a new technical analysis signal. During similar occasions, PACIFIC BIOSCIENCES OF CALIF shares had a median return of +33.9%, over the following 2 months – based on 10 historical occasions with 7 of those showing positive returns (70%). This buy signal for PACIFIC BIOSCIENCES OF CALIF received a high score of 7.5 (out of 10). This insight was generated on 2022-September-7 with last price of 5.86.

What’s This Token About?

PACIFIC BIOSCIENCES OF CALIF is in the Diagnostic Equipment business. Based on the last 2 years’ risk/return profile, this asset is seen as Very Risky. Ticker symbol: PACB US.

What’s My Risk / Reward and Time Horizon?

We found 2 months to be the optimal trade horizon, after testing a number of possible alternatives (accuracy of previous returns). Otherwise consider closing out this trade once the target level of 7.85 (+33.9%) has been reached. Based on PACIFIC BIOSCIENCES OF CALIF’s recent up and down swings, LongShortBets suggests considering to set a stop loss level for this insight at 4.96 (last price at 5.86), which is equivalent to a -15.4% decline.

Returns during similar periods:

The chart above shows the previous returns (in %) based on similar setups with the most recent ‘insight’ shown under (1), the second most recent ‘insight’ under (2), etc.

Previous episodes:

23.4% (June-2022), 113.6% (November-2020), 122.6% (August-2020), 57.1% (May-2020), 15.3% (February-2020), 53.3% (June-2018), 44.4% (March-2018), -0.8% (January-2018), -9.8% (October-2017), -43.5% (July-2017).

Historical Chart:


Star (1 to 10)7.5
Time2 months
Hit Rate70%

Leave a Reply